Live Breaking News & Updates on Medica therapeutics inc

Stay updated with breaking news from Medica therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DiaMedica Therapeutics (DMAC) to Release Earnings on Wednesday

DiaMedica Therapeutics (DMAC) to Release Earnings on Wednesday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Craig-hallum , Diamedica-therapeutics-company-profile , Nasdaq , Diamedica-therapeutics-inc , Diamedica-therapeutics , Get-free-report , Medica-therapeutics , Medica-therapeutics-inc , Diamedica-therapeutics-daily ,

DiaMedica Therapeutics (DMAC) Set to Announce Earnings on Wednesday

DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link. DiaMedica Therapeutics (NASDAQ:DMAC […]

Craig-hallum , Diamedica-therapeutics-inc , Diamedica-therapeutics , Get-free-report , Medica-therapeutics , Medica-therapeutics-inc , Diamedica-therapeutics-daily , Nasdaq-dmac , Dmac , Medical , Earnings ,

Craig Hallum Begins Coverage on DiaMedica Therapeutics (NASDAQ:DMAC)

Craig Hallum Begins Coverage on DiaMedica Therapeutics (NASDAQ:DMAC)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Craig-hallum , Stonebridge-capital-advisors , Nasdaq , Diamedica-therapeutics-inc , Paragon-associates-ii-joint-venture , Avantax-advisory-services-inc , Diamedica-therapeutics , Free-report , Medica-therapeutics , Get-free-report , Capital-advisors , Paragon-associates

Craig Hallum Lowers DiaMedica Therapeutics (NASDAQ:DMAC) Price Target to $8.00

DiaMedica Therapeutics (NASDAQ:DMAC – Free Report) had its target price trimmed by Craig Hallum from $11.00 to $8.00 in a research note published on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. Separately, Oppenheimer reiterated an outperform rating and issued a $6.00 price objective (down previously from $7.00) on […]

Craig-hallum , Avantax-advisory-services-inc , Citadel-advisors , Stonebridge-capital-advisors , Diamedica-therapeutics-inc , Diamedica-therapeutics , Free-report , Medica-therapeutics , Get-free-report , Street-group , Advisory-services , Medica-therapeutics-inc

DiaMedica Therapeutics (NASDAQ:DMAC) Trading Up 0.7%

Shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report) were up 0.7% during mid-day trading on Thursday . The company traded as high as $3.02 and last traded at $2.91. Approximately 44,769 shares traded hands during trading, a decline of 42% from the average daily volume of 77,022 shares. The stock had previously closed […]

Charles-schwab-investment-management-inc , Diamedica-therapeutics-inc , Stonebridge-capital-advisors , Nasdaq , Renaissance-technologies , Diamedica-therapeutics , Get-free-report , Medica-therapeutics , Schwab-investment-management , Capital-advisors , Street-group

DiaMedica Therapeutics (NASDAQ:DMAC) Stock Price Down 8.6%

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report) shares fell 8.6% on Monday . The company traded as low as $2.50 and last traded at $2.56. 183,312 shares changed hands during trading, an increase of 113% from the average session volume of 85,998 shares. The stock had previously closed at $2.80. Wall Street Analyst Weigh […]

Diamedica-therapeutics-company-profile , Renaissance-technologies , Citadel-advisors , Dimensional-fund-advisors , Nasdaq , Diamedica-therapeutics-inc , Diamedica-therapeutics , Get-free-report , Medica-therapeutics , Fund-advisors , Street-corp

DiaMedica Therapeutics (DMAC) Set to Announce Earnings on Monday

DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Monday, August 14th. Analysts expect the company to announce earnings of ($0.22) per share for the quarter. DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) last announced its quarterly earnings data on Monday, May 15th. The […]

Scott-kellen , Davidj-wambeke , Dimensional-fund-advisors , Citadel-advisors , Diamedica-therapeutics-inc , Renaissance-technologies , Securities-exchange-commission , Diamedica-therapeutics , Get-free-report , Medica-therapeutics , Exchange-commission , Street-group

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Sees Significant Increase in Short Interest

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Sees Significant Increase in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Randall-michael-giuffre , Dimensional-fund-advisors , Nasdaq , Renaissance-technologies , Citadel-advisors , Catalyst-financial-partners , Diamedica-therapeutics-inc , Securities-exchange-commission , Diamedica-therapeutics , Get-free-report , Director-randall-michael-giuffre , Exchange-commission

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Sees Significant Growth in Short Interest

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report) was the target of a large growth in short interest in July. As of July 15th, there was short interest totalling 796,100 shares, a growth of 11.6% from the June 30th total of 713,600 shares. Approximately 4.5% of the shares of the stock are sold short. Based […]

Randall-michael-giuffre , Catalyst-financial-partners , Dimensional-fund-advisors , Nasdaq , Citadel-advisors , Renaissance-technologies , Diamedica-therapeutics-inc , Securities-exchange-commission , Diamedica-therapeutics , Get-free-report , Koch-thomas-von , Director-randall-michael-giuffre

Insider Buying: DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Major Shareholder Acquires $4,999,999.20 in Stock

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Free Report) major shareholder Koch Thomas Von bought 1,470,588 shares of DiaMedica Therapeutics stock in a transaction on Friday, June 23rd. The shares were acquired at an average price of $3.40 per share, for a total transaction of $4,999,999.20. Following the completion of the acquisition, the insider now owns 4,326,435 […]

Diamedica-therapeutics-inc , Securities-exchange-commission , Nasdaq , Citadel-advisors , Catalyst-financial-partners , Renaissance-technologies , Diamedica-therapeutics-company-profile , Diamedica-therapeutics , Free-report , Koch-thomas-von , Exchange-commission